A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

Recruiting

Phase 3

CagriSemaA Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

Sponsor:

Novo Nordisk A/S

Code:

NCT07011667

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CagriSema (Cagrilintide B and Semaglutide I)

Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-27. This information was provided to ClinicalTrials.gov by Novo Nordisk A/S on 2025-06-11.